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Abstract
Background: Postal questionnaires are widely used to collect outcome data on participants.
However, a poor response to questionnaires will reduce the statistical power of the study and may
introduce bias. A meta analysis of ten trials offering study results, largely in the fields of education
and marketing, was shown to be ineffective, with the odds ratio for response with offering research
findings is 0.92 (95% CI 0.75 to 1.11). However uncertainty still exists as it is uncertain whether
results from such trials can be extrapolated to that of a health care setting. The aim of this study
was to assess whether offering participants study results increases the response rates to postal
questionnaires.
Methods: 1038 women aged over 70 years were remotely randomised by computer in a 3:1 ratio.
250 participants did not receive the offer of knowing the results of the trial and 788 participants
were offered the results of the trial in a postal questionnaire. The main outcome measure was
response rate. Chi square test was used to evaluate the overall differences in response rate
between the two groups. An adjusted analysis, adjusting for whether the participant was taking
calcium and age was also undertaken.
Results: The response rates were not significantly different Odds Ratio 0.88 (95% confidence
intervals 0.48 to 1.63) p = 0.69.
Conclusion: Offering study results to women living in the community aged over 70 does not
increase response rates to postal questionnaires. Although researchers have an ethical obligation
to offer participants study results, since 10% of women did not wish to receive the results,
investigators should give participants the option to opt out of receiving the study's results.
Background
Postal questionnaires are widely used to collect data on
participants in health research. They are an attractive
means of collecting data, because they are easy to admin-
ister and may be the only economically viable method of
collecting data on large numbers of participants who may
be geographically dispersed. However, if there is a poor
response rate to these questionnaires the validity of the
study may be at risk for two main reasons. First, the statis-
tical power of the study will be reduced. Second, bias may
be introduced if non-responders differ significantly from
those who do respond. In other words low response can
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can be introduced and the external validity of surveys are
undermined as non-response will prevent random sam-
pling. Identifying effective strategies to increase response
rates to postal questionnaires is therefore highly relevant
to researchers since it could improve the quality of their
research.
Offering participants the chance of being informed of the
results of the study in which they are participating could
improve response rates for three reasons. First it demon-
strates the researcher's goodwill and sincerity [1,2]. Sec-
ond, it adds greater credibility and importance to the
respondent's efforts and third, it could act as a non-mon-
etary incentive. In 2002 Edwards [3] identified 75 differ-
ent strategies for increasing response rates including non-
monetary incentives versus no incentive, which were
shown to be effective (odds ratio of 1.19 95% confidence
interval 1.11 to 1.28). In 2004 the same review group
reported the results of a meta analysis of ten trials offering
study results as an incentive which included 13 642 par-
ticipants [4]. When the results of these trials were pooled
in a random effects meta analysis the odds ratio for
response with research findings was 0.92 (95% CI 0.75 to
1.11). However, uncertainty still exists as to the effective-
ness of this strategy in a health care setting. This is because
only one of these trials [5] was undertaken in a health care
setting. The results of this study showed no evidence to
suggest that promising study results to participants
increases response rates. However, participants were hos-
pital chief executives who were sent questionnaires
regarding managerial issues such as expenditure and not
items directly relating to their health. The effectiveness of
this strategy has yet to be tested in a setting related directly
to the population's health and it is uncertain whether tri-
als conducted in other areas such as marketing and educa-
tion can be extrapolated to a health care setting. The aim
of this study therefore was to assess whether offering to
tell participants the results of the study would increase the
response rates to postal questionnaires in a health care
setting
Methods
Study population
The subjects in this study were community dwelling
women aged over 70 living in the York and Cumbria area.
These women were due to be sent a final follow-up ques-
tionnaire as part of a multi-centred randomised control-
led trial of calcium and vitamin D supplementation for
fracture prevention. Participants had been originally
assigned to one of two groups. The intervention group
received daily oral supplementation of 1,000 mg of cal-
cium with 800 IU vitamin D3 with a patient information
leaflet on dietary calcium intake and falls prevention. The
control group received the patient information leaflet
only. Further details of this trial have been reported else-
where [6].
Inclusion/exclusion criteria and randomisation
Women were eligible for this trial if they had been
recruited from the York centre and were due to receive
their final follow-up questionnaire in March 2004.
Women were excluded if they had withdrawn from the
trial or if notification of the participant's death had been
received. An independent researcher from the York Trials
Unit randomised eligible women in a 3:1 ratio in favour
of offering the results of the trial, by computer. An une-
qual randomisation ratio was used for two reasons. First,
there was an issue of administrative convenience. The
'standard' letter to trial participants was to offer them the
study results and this letter was going out to all centres
including those not participating in this study. Therefore,
it was less costly with lower administrative input to pro-
duce a smaller separate batch of letters to send out than if
we had used equal allocation. Second, although we had
some uncertainty with respect to the direction of the effect
(hence the trial) on balance we expected that the response
rates would be lower in the group assigned to 'not offered
the results.' If this had been the case and more participants
were assigned to this group, then the overall response rate
to the final follow-up would have been reduced.
Control
250 women assigned to the group 'not offered the results'
of the trial received a one-page questionnaire asking
whether the participant had had a fracture in the past
three years, how much calcium and vitamin D supple-
ment they were taking and if applicable the reason for
stopping the supplement, along with a request to give per-
mission to send details of future research. However, all
Table 1: Baseline characteristics of participants
Baseline Variable Intervention Control
Age (mean, SD) 76.2 (4.41) 77.09 (5.34)
Weight (Kilos, mean SD) 65.23 (11.88) 65.65 (12.45)
Percent (n) < 58 kilos 31.2% (231/740) 30.8% (72/234)
Prior any fracture 59.0% (454/770) 61.5% (152/247)
Smoker 5.8% (32/551) 5.4% (9/166)
Poor/Fair Health 33.8% (260/769) 28.7% (71/247)
Maternal hip fracture 13.6% (105/770) 15.0% (37/247)
Fall in previous 12 months 31.6% (243/770) 36.8% (91/247)
Taking anti-fracture treatment 5.5% (42/770) 3.2% (8/247)
SF12
MCS (mean; SD) 52.20 (9.05) 53.00 (8.66)
PCS (mean; SD) 41.33 (11.88) 40.28 (11.60)
Euroqol 0.73 (0.218) 0.69(0.26)Page 2 of 5
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informed of the trial's results.
Intervention
788 women assigned to 'offered the results' received the
same questionnaire but with an additional question ask-
ing whether they would like to be notified of the results of
the trial.
Both groups received a personalised cover letter showing
university sponsorship, along with a business reply enve-
lope. Those participants not returning a questionnaire
within three weeks were sent up to two reminder letters,
questionnaires and business reply envelopes, three and six
weeks after the initial mailing. Administration of the
questionnaire was not blind to group allocation.
Ethical approval for the study was obtained from the
Northern and Yorkshire multicentre research ethics com-
mittee and relevant local research ethics committees.
Outcome
The primary outcome was return of final follow-up ques-
tionnaire or reminder by the participant.
Sample size and statistical analysis
The sample size for this study was calculated to give 95%
power (5% two sided significance) to detect a 10% differ-
ence in response rates. We assumed that the baseline
response rate would be approximately 80%, a figure based
on work from a previous trial conducted by the authors on
women of a similar age and risk of fracture [7]. Results
were analysed using SPSS 11. All participants were
included in the analysis (intention to treat). We used Chi
square test to evaluate the overall differences in response
rate between the two groups. We also undertook an
adjusted analysis, adjusting for whether the participant
was taking calcium and age. Statistical analysis was not
undertaken blind to group allocation.
Results
The baseline characteristics for the participants are shown
in table 1 whilst figure 1 describes the participant recruit-
ment profile. The overall response rates are shown in table
2. A total of 153 participants were sent reminder question-
naires,112 of which were in the intervention group and 41
in the control group. 63 participants (56%) in the inter-
vention group and 27 participants (66%) in the control
group returned a reminder. These response rates were not
significantly different. Chi square = 0.16 df = 1 p = 0.69
Odds Ratio (OR) 0.88 (95% Confidence Intervals [CI]
0.48 to 1.63). As the study was a factorial design, the data
were tested to ensure there was no interaction between
taking calcium and being allocated to being either
offered/not offered the results of the trial. Adjusted OR for
returning the postal questionnaire showed no association
between offering the results of the trial and the return of
the questionnaire (OR 0.81 [CI 0.44 to 1.51] p = 0.51)
whilst taking calcium significantly predicted (OR 5.10 [CI
2.02 to 12.84] p = 0.001) the return of the questionnaire
as did increasing age, but to a lesser degree (OR 1.05 [CI
1.00 to 1.11] p = 0.05).
Of the 721 participants returning questionnaires in the
group offered the results of the trial, 647 (89.7.%)
Origin and flow of participants in trialFigure 1
Origin and flow of participants in trial.
Assessed for
eligibility (n=1426)
Excluded (n=388)
Not meeting inclusion
criteria (n=353)
Died (n=28)
Moved away no
forwarding address
given (n=7)
Randomised (n=1038)
Allocated to control
(n=788)
Received allocated control
(n=787)
Did not receive allocated
control (n=1)
Post office unable to deliver
letter (n=1)
Allocated to intervention
(n=250)
Received allocated intervention
(n= 249)
Did not receive allocated
intervention (n=1)
Post office unable to deliver
letter (n=1)
Analysed (n=770)
Lost to follow-up
Died (n=11)
Moved away no forwarding
address (n=6)
Lost to follow-up
Died (n=1)
Moved away no forwarding
address (n=1)
Analysed (n=247)
Table 2: Response rate to final follow up questionnaire
Intervention Control
Replied 721 233
Not replied 49 14
Total number of questionnaires analysed 770 247
Overall response rate 93.6% 94.3%Page 3 of 5
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group 'not offered the results' pro-actively asked to be sent
a copy of the results. The baseline characteristics of partic-
ipants who did and did not request the study's results are
reported in table 3. Adjusted OR showed taking calcium
(OR 4.00 [CI 1.88 to 8.51]) p < 0.05) significantly pre-
dicted whether participants requested trial results, how-
ever age (OR 0.96 [CI 0.91 to 1.01]) p = 0.12) and fair or
poor health (OR 0.66 [CI 0.40 to 1.10]) p = 0.11) did not
predict whether participants requested trial results.
The characteristics of those who did and did not respond
to the questionnaire are reported in table 4.
Discussion
This study found no evidence that offering study results to
participants increased the response rate to a postal ques-
tionnaire. There are two possible reasons for this strategy
being ineffective. First, offering results of the trial may not
act as an incentive to participants to respond because it
appeals only to those interested in the trial and who were
likely to respond anyway. If this were the case then offer-
ing the results of the trial was insufficient incentive to
motivate non-responders. Second, the following strategies
were adopted which are known to increase response rate;
a short, one-sided, straightforward questionnaire
designed to be of interest to participants but not contain-
ing sensitive questions, reminders with a second copy of
the questionnaire and university sponsorship. This com-
bination of strategies produced a high response rate of
over 93% and it may be that any strategy would struggle
to significantly increase the response rate further (i.e., a
ceiling effect).
This study was undertaken among women over 70 living
independently in the community therefore it is not possi-
Table 3: Baseline characteristics of participants who did and did not request the trial's results
Baseline Variable Requested trial results Did not request trial results
Age (mean, SD) 76.00 (4.30) n = 647 76.80 (4.68) n = 74
Weight (Kilos, mean SD) 65.59 (11.94) n = 618 64.28 (11.77) (n = 71)
Percent (n) < 58 kilos 30.7% (190/618) 32.4% (23/71)
Prior any fracture 59.2% (383/647) 53.4% (39/73)
Smoker 4.5% (21/463) 3.8% (2/52)
Poor/Fair Health 31.9% (206/646) 41.7% (30/72)
Maternal hip fracture 13.3% (86/647) 16.7% (12/72)
Fall in previous 12 months 31.1% (201/647) 31.9% (23/72)
Taking anti-fracture treatment 5.9% (38/647) 4.2% (3/73)
SF12
MCS (mean; SD) 52.61 (8.49) n = 629 50.98 (11.5) n = 70
PCS (mean; SD) 41.73 (11.8) n = 629 39.65 (11.20) n = 70
Euroqol 0.74 (0.21) n = 640 0.75 (0.19) n = 71
Table 4: Baseline characteristics of responders and non-responders
Variable Responders Non-responders p value
Age (mean, SD) 76.32 (4.62) n = 954 77.43 (5.22) n = 63 0.07
Weight (Kilos, mean SD) 65.54 (12.06) n = 912 62.29 (10.93) 0.04
Percent (n) < 58 kilos 30.8% (281/912) 35.5% (22/62) 0.02
Prior any fracture to randomisation 59.4% (567/954) 61.9% (39/63) 0.80
Smoker 4.5% (30/671) 23.9% (11/46) < 0.05
Poor/Fair Health 31.7% (302/953) 46.0% (29/63) 0.03
Maternal hip fracture 14.0% (134/954) 12.7% (8/63) 0.91
Falls in 12 month prior to randomisation 32.3% (308/954) 41.3% (26/63) 0.18
Taking anti-fracture treatment 5.0% (48/954) 3.2% (2/63) 0.72
SF12
MCS (mean; SD) 52.63 (8.78) n = 929 48.53 (10.6) n = 60 0.01
PCS (mean; SD) 41.29 (11.68) n = 929 37.66 (13.36) n = 60 0.02
Euroqol 0.73 (0.22) n = 938 0.62 (0.30) n = 62 0.01Page 4 of 5
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ble to generalise these results to either men, women
younger than 70 or to those living in nursing homes or
other forms of residential care. Also because the partici-
pants had already agreed to take part in a randomised con-
trolled trial the results may not apply to the wider
population of women over 70 years. The incentive of
'offering trial results' was tested in combination with
other strategies known to increase response rates, which
together produced an excellent response rate, which any
strategy would find difficult to improve upon. It may be
that this incentive is effective in a different combination of
strategies.
Conclusion
Although offering the results of the study did not increase
the response rates, researchers do have an ethical
obligation to offer participants the results of study if they
wish to receive them. Our results show that 90% of
women did want to know the results of our trial however,
10% did not wish to receive the results, which emphasises
the need for investigators to give participants the option
to 'opt out of' receiving the trial's results. Within the UK,
for new studies the issue of disseminating study results
will have to be addressed since the introduction of the
new Research Ethics Committee (REC) form in 2004. The
investigator is asked whether the study's results will be dis-
seminated to participants and details of what will happen
to the results of the research, when the results are likely to
be published and how participants can obtain a copy of
the results needs to be stated on the patient information
leaflet.
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